Investor Ideas #Potcasts: #Cannabis News and #Stocks on
the Move - (CSE: $CBDT.C), (CSE: $MTEC.C), (TSX:
$ACB.TO), (TSXV: $META.V), (TSX: $WEED.TO)
Delta, Kelowna, BC –April 18,
2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insights from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/04181CBDC-MTEC-ACB-META-WEED.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another Investorideas.com “potcast” looking at
cannabis news, stocks to watch as well as insights from experts and industry
leaders.
Today
we are looking at announcements from EMPOWER CLINICS INC. (CSE: CBDT), Cannvas MedTech Inc. (CSE: MTEC) (OTCPK: CANVF), Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB), National Access Cannabis Corp. (TSXV: META),Pure Global Cannabis Inc. (TSX.V: PURE) (OTC: PRCNF) and Canopy Growth Corporation (TSX: WEED) (NYSE: CGC).
EMPOWER CLINICS
INC. . (CSE: CBDT), a growth oriented, diversified health and
wellness company, announced the signing of a pilot agreement with
Cannvas MedTech Inc., (CSE: MTEC) (OTCPK: CANVF), a leading digital cannabis
education and analytics company, to launch a comprehensive education, data
collection and analysis program starting with the installation of a network of
standalone on-site Cannvas Kiosks in the Empower network of medical clinics.
"This
is an opportunity to bring unbiased cannabis education to a large population of
patients looking for therapies to alleviate a number of ailments while also
learning more about what behaviours may drive the decision to look at cannabis
as an alternative or complementary treatment," said Shawn Moniz, Chief
Executive Officer, Cannvas MedTech. "We are thrilled to partner with
Empower Clinics to couple cannabis education with data analysis and better
serve their patients while growing the Cannvas brand across the United
States."
The
partnership installs Cannvas as the exclusive provider of cannabis education to
Empower Clinics and its 120,000 patients in the U.S. Cannvas plans to place its
Cannvas Kiosks throughout Empower's network of clinics to provide accessible
and unbiased cannabis education to its patients, integrating geo-targeting
capabilities to ensure relevant contextual information across the country.
Cannvas will also be a key data and analytics partner for Empower, providing
meaningful insights on customer behaviours and industry trends and integrating
mutually beneficial existing data partnerships.
Aurora Cannabis
Inc. . (TSX: ACB) (NYSE: ACB)confirmed today that, further to its press
release dated April 5, 2019, the public appeal process related to the German
cannabis production tender has been completed, and Aurora's contract with the German Federal Institute for Drugs and
Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte BfArM) has
now been finalized.
The
approval will allow Aurora to begin construction of a new, state-of-the art,
indoor cannabis production facility in Leuna, Germany in May 2019 and the
Company anticipates completion within 12 months of ground breaking. Initial
shipments of locally grown cannabis are expected to become available to German
medical patients starting in October 2020, with the new facility producing a
minimum of 4,000 kg over a four-year period, to be expanded over time as
regulations permit.
"We
are thrilled with the positive outcome of the tender process, and excited to
start construction on our latest production facility," said Neil Belot,
Chief Global Business Development Officer. "We are very proud of the work
done by our European team. In addition
to providing German medical patients with a local supply of high-quality,
medical grade cannabis, this new facility will also bring additional new jobs
to the German labour market. It's a strong validation of our production and
distribution standards to have been recognized as having the highest-rated
overall concept out of 79 tender applications, and we look forward to
continuing to increase availability of medical cannabis in this important
market."
National Access
Cannabis Corp. . (TSXV: META), Canada's largest private cannabis
retailer, today announced it has closed the previously
announced acquisition of Saskatchewan-based New Leaf Emporium Inc. ("New
Leaf Emporium") and will take full operation of the New Leaf Emporium
retail cannabis store and offer online sales throughout Saskatchewan.
"Today
we're operating in three provinces," said Mark Goliger, CEO of NAC.
"No other cannabis retailer has our provincial footprint. We're the
national leader in cannabis retail, having opened 24 stores to date in the
complex regulatory markets of Alberta, Manitoba, and Saskatchewan, however, the
journey is just beginning for our Company and our industry. Our team is focused on building our national
retail footprint to 40 stores by the end of calendar 2019, and to 110 stores by
the end of calendar 2020. British Columbia is our next target market, followed
by Ontario."
NAC
will take full operation of the New Leaf Emporium retail cannabis store, open
since October 22, 2018, in central Moose Jaw at the corner of Main and
Athabasca and offer online sales throughout Saskatchewan. The New Leaf Emporium
store is one of only two stores serving Moose Jaw's population of 35,000.
The
Company currently has 24 cannabis retail locations open in total, distributed
provincially as follows: 14 in Alberta, 9 in Manitoba and 1 in Saskatchewan.
In
addition to the 24 bricks and mortar stores, NAC is also allowed to sell via
its e-commerce platform in the provinces of Manitoba and Saskatchewan, based on
provincial regulations.
Pure Global
Cannabis Inc. (TSX.V: PURE) (OTC: PRCNF) , an integrated, growth-oriented life sciences and consumer products
cannabis company, operating through its wholly-owned subsidiary PureSinse Inc.,
announced that it has entered into a binding
Letter of Intent with Ottawa-based The Great Canadian Hemp Company, Ltd.,
pursuant to which the parties shall seek to enter into a share purchase
agreement whereby Pure Global will acquire a 100% interest in GCHC.
As
consideration, Pure Global will pay GCHC shareholders $560,000 with $60,000
payable in cash and $500,000 payable through the issuance of common shares in
the capital of Pure Global at a price equal to $0.20 per share to be held in
escrow and released pursuant to a 24-month schedule.
GCHC
creates organic vegan hemp-based, all-natural skin and hair products, and
promotes sustainability, organic beauty, and mindfulness. After the
acquisition, GCHC will continue as a business unit of PureSinse.
"The
Great Canadian Hemp Company is a young, innovative, already-established company
that offers an exciting opportunity for Pure Global to enter the health and
beauty segment," said Ross Hendry, VP of Consumer Sales and Marketing.
"Melissa and Edan are great brand ambassadors, and have established a line
of turnkey products that will transfer successfully into CBD and full-medicated
spectrum products. We will scale manufacturing of these amazing products and
leverage our distribution capabilities. This line is especially geared for the
European and Asian markets where there is currently an enormous demand for CBD
health and beauty products."
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and Acreage Holdings, Inc. (CSE: ACGR.U) (OTC: ACRGF) announced that they have entered into a
definitive arrangement agreement that grants Canopy Growth the right to acquire
100 percent of the shares of Acreage, with a requirement to do so at such time
as cannabis production and sale becomes federally legal in the United
States, subject to obtaining
the requisite prior approval of the shareholders of each of Acreage and Canopy
Growth, respectively, as well as the approval of the Supreme Court of British
Columbia.
Following
the approval of Canopy Growth and Acreage shareholders as well as the Supreme
Court of British Columbia, under the terms of the arrangement agreement,
Acreage Holders will receive an immediate aggregate total payment of US$300
million or approximately US$2.55 per Acreage Subordinate Voting Share based on
the currently outstanding Subordinate Voting Shares of Acreage and conversion
of certain convertible securities.
In addition, upon the exercise of the Right, holders of subordinate voting
shares of Acreage will receive 0.5818 of a common share of Canopy Growth for
each Acreage Subordinate Voting Share held at the time of closing of the
Transaction. Upon exercise of the Right, the total consideration payable
pursuant to the Transaction is valued at approximately US$3.4 billion on a
fully-diluted basis, represents a premium of 41.7% over the 30-day volume
weighted average price of the Acreage Subordinate Voting Shares on the Canadian
Securities Exchange ending April 16, 2019.
The Companies will also execute a
licensing agreement granting Acreage access to Canopy Growth's award-winning
line-up of brands such as Tweed and Tokyo Smoke, along with other intellectual
property. Once the Right is exercised, Acreage will become part of a leading
global cannabis company with access to markets beyond the U.S. Until then, the
two companies will continue to operate independently.
"Today we announce a complex
transaction with a simple objective. Our right to acquire Acreage secures our
entrance strategy into the United States as soon as a federally-permissible
pathway exists," said Bruce Linton, Chairman and co-CEO, Canopy Growth.
"By combining Acreage's management team, licenses and assets with Canopy
Growth's intellectual property and brands, there will be tremendous value
creation for both companies' shareholders."
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available
on iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via
Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big
Investing Ideas
Investorideas.com
is a recognized news source publishing third party news and press releases plus
we create original financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts
and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto
Corner and Podcast, Play by Play sports and stock news column, Investor
Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change
Podcast and the AI Eye Podcast and column covering
developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investing involves risk and possible losses. This site is currently compensated
for news publication and distribution, social media and marketing, content
creation and more. Disclosure is posted for each compensated news release,
content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp
Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
and tickertagstocknews.com
Global investors must adhere to regulations of each
country.
Please read Investorideas.com privacy policy:
Investor Ideas does
not condone the use of cannabis except where permissible by law. Our site does
not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment